USFDA makes 'certain' observations for Torrent Pharma's Indrad plant

The audit at Indrad plant of the company was carried out by the United States Food and Drug Administration (USFDA) in April.

from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2IKhS0K
via IFTTT